Tags

Type your tag names separated by a space and hit enter

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse.
J Neurol. 2020 May 28 [Online ahead of print]JN

Authors+Show Affiliations

Department of Neurology, Hannover Medical School, Hannover, Germany.Department of Neurology, Hannover Medical School, Hannover, Germany.Department of Neurology, Hannover Medical School, Hannover, Germany.Department of Neurology, Hannover Medical School, Hannover, Germany.Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.Department of Neurology, Hannover Medical School, Hannover, Germany.Department of Neurology, Hannover Medical School, Hannover, Germany. skripuletz.thomas@MH-Hannover.de.

Pub Type(s)

Letter

Language

eng

PubMed ID

32494855

Citation

Möhn, Nora, et al. "Mild COVID-19 Symptoms Despite Treatment With Teriflunomide and High-dose Methylprednisolone Due to Multiple Sclerosis Relapse." Journal of Neurology, 2020.
Möhn N, Saker F, Bonda V, et al. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse. J Neurol. 2020.
Möhn, N., Saker, F., Bonda, V., Respondek, G., Bachmann, M., Stoll, M., Wattjes, M. P., Stangel, M., & Skripuletz, T. (2020). Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse. Journal of Neurology. https://doi.org/10.1007/s00415-020-09921-1
Möhn N, et al. Mild COVID-19 Symptoms Despite Treatment With Teriflunomide and High-dose Methylprednisolone Due to Multiple Sclerosis Relapse. J Neurol. 2020 May 28; PubMed PMID: 32494855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse. AU - Möhn,Nora, AU - Saker,Firas, AU - Bonda,Viktoria, AU - Respondek,Gesine, AU - Bachmann,Marcus, AU - Stoll,Matthias, AU - Wattjes,Mike P, AU - Stangel,Martin, AU - Skripuletz,Thomas, Y1 - 2020/05/28/ PY - 2020/04/29/received PY - 2020/05/14/accepted PY - 2020/05/13/revised PY - 2020/6/5/entrez PY - 2020/6/5/pubmed PY - 2020/6/5/medline JF - Journal of neurology JO - J. Neurol. SN - 1432-1459 UR - https://www.unboundmedicine.com/medline/citation/32494855/Mild_COVID-19_symptoms_despite_treatment_with_teriflunomide_and_high-dose_methylprednisolone_due_to_multiple_sclerosis_relapse L2 - https://dx.doi.org/10.1007/s00415-020-09921-1 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.